✦ LIBER ✦

32 Single-agent Gemzar® (Gemcitabine, GEM) versus cisplatin plus etoposide (CE): A randomized phase II study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by Manegold, Ch.; Stahel, R.; Mattson, K.; Ricci, S.; van Walree, N.C.; Bergman, B.; ten Bokkel Huinink, W.W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1BA Phase III study of pemetrexed plus c

✍ C. Manegold; R. Digumarti; M. Zukin; F. de Marinis; A. Mellemgaard; D. Gandara; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Randomized phase II study of gemcitabine

✍ Kim, Jee Hyun; Kim, Si Young; Jung, Kyung Hae; Park, Keunchil; Suh, Cheol Won; L 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Randomized, multicenter, phase II study

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Gemcitabine and carboplatin in patients

✍ Kortsik, C; Albrecht, P; Elmer, A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 97 KB

17 Phase II trial of gemcitabine plus ci

✍ Ryu, Jeong-Seon; Kim, Se-Kyu; Kim, Young-Chul; Park, Jae-Yong; Jung, Eun-Taik; J 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

793 Multicenter phase II study of gemcit

✍ F. Cappuzzo; S. Novello; F. De Marinis; M. Maur; G. Scagliotti; S. Salvagni; E. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB